Share This Post

Kidney Cancer Drug Shows Promise in Early Trial

From Health Day News

An experimental drug may show promise in treating kidney cancer, researchers say.

The drug CB-839 is the first to target an enzyme that cancer cells require to stay alive, researchers said. This stage 1 clinical trial found that the drug was effective in most patients with advanced kidney cancer when used in combination with another cancer drug called everolimus (Afinitor, Zortress).

Read more here:

Share This Post

Dena Battle is the President and cofounder of KCCure.

Lost Password

Register

Subscribe for updates!